Liver Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Liver Cancer stocks.

Recent Signals

Date Stock Signal Type
2021-04-14 ABUS MACD Bullish Signal Line Cross Bullish
2021-04-14 ABUS 20 DMA Resistance Bearish
2021-04-14 ALNY Pocket Pivot Bullish Swing Setup
2021-04-14 ALNY 20 DMA Resistance Bearish
2021-04-14 ALNY Bollinger Band Squeeze Range Contraction
2021-04-14 CLSN Narrow Range Bar Range Contraction
2021-04-14 CLSN 200 DMA Support Bullish
2021-04-14 DCTH NR7 Range Contraction
2021-04-14 DCTH Narrow Range Bar Range Contraction
2021-04-14 DCTH Doji - Bullish? Reversal
2021-04-14 ISR Narrow Range Bar Range Contraction

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults, and is the most common cause of death in people with cirrhosis.It occurs in the setting of chronic liver inflammation, and is most closely linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins such as alcohol or aflatoxin. Certain diseases, such as hemochromatosis and alpha 1-antitrypsin deficiency, markedly increase the risk of developing HCC. Metabolic syndrome and NASH are also increasingly recognized as risk factors for HCC.As with any cancer, the treatment and prognosis of HCC vary depending on the specifics of tumor histology, size, how far the cancer has spread, and overall health.
The vast majority of HCC occurs in Asia and sub-Saharan Africa, in countries where hepatitis B infection is endemic and many are infected from birth. The incidence of HCC in the United States and other developing countries is increasing due to an increase in hepatitis C virus infections. It is more common in males than females for unknown reasons.

More about Liver Cancer
Browse All Tags